|Articles|December 1, 2001

December 2001
Volume 7
Issue 12

Financial Risk, Plans Types, and Authorizations for Managed Alcohol Treatment Services

Author(s)Paul R. Marques, PhD, Eduard Zaloshjna, PhD, Ted R. Miller, PhD

Download PDF: Financial Risk, Plans Types, and Authorizations for Managed Alcohol Treatment Services

Articles in this issue

over 24 years ago

Article

A Pneumonia Practice Guideline and a Hospitalist-Based Reorganization Lead to Equivalent Efficiency Gains

over 24 years ago

Article

Leading the Way: Managed Care for Patients Near the End of Life

over 24 years ago

Article

The Greater Acceptance and Utilization of Nurse Practitioners

over 24 years ago

Article

End-of-life Care: A Public Health Crisis and an Opportunity for Managed Care

over 24 years ago

Article

Fall History Is an Independent Predictor of Adverse Health Outcomes and Utilization in the Elderly

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

Financial Risk, Plans Types, and Authorizations for Managed Alcohol Treatment Services

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug

New York Experts Push for Coordinated Obesity Care Teams

As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning

Grocery Assistance Benefit Linked to Fewer Diabetes Complications

FDA Clears First Single-Biomarker Blood Test for Alzheimer